Pfizer settles lawsuit from BYU over Celebrex case

PAUL FOY
May 1, 2012

SALT LAKE CITY (AP) — Pfizer Inc. has announced the settlement of a multi-billion-dollar lawsuit filed by Brigham Young University over development of the blockbuster painkiller Celebrex.

Terms of the settlement weren't disclosed by the drug company or the Mormon Church-owned university in Utah. The settlement was announced Tuesday in a confidential agreement.

BYU's lawsuit says a chemistry professor, Daniel Simmons, discovered the genetic workings of the drug in the early 1990s. It accused Pfizer of violating a research agreement the school made with predecessor companies.

As part of the settlement, BYU plans to endow a Dan Simmons Chair in recognition of his lifelong work advancing human health.

BYU says Simmons' research for Celebrex was among the most important pharmacological discoveries of the past two decades.